Antipsychotic medications spur surprisingly little improvement in the mental prowess of people with chronic schizophrenia, a national investigation finds. Patients who were prescribed any of several new antipsychotic drugs, often touted as effective at boosting thinking skills in people with schizophrenia, displayed only modest increases in mental agility during the first 6 months of treatment.
The drugs’ effects were no better than the effects of an older antipsychotic substance, according to a team led by psychologist Richard S.E.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.